Hikma pharmaceuticals stock
WebApr 12, 2024 · HKMPF Stock Forecast, Price & News (Hikma Pharmaceuticals) Free Trial Research Tools My MarketBeat My Portfolio My Performance My Insights My Headlines My Calendar My Ratings My Insider Trades My Earnings My SEC Filings My Social My Newsletter My Portfolio Ideas My Account Calculators Dividend Calculator Dividend Yield … WebApr 12, 2024 · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe.
Hikma pharmaceuticals stock
Did you know?
WebApr 12, 2024 · Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three... Web2 days ago · Hikma Pharmaceuticals : 2024 beat + expected 2024 recovery MarketScreener Homepage Equities United Kingdom London Stock Exchange Hikma Pharmaceuticals PLC News Summary HIK GB00B0LCW083 HIKMA PHARMACEUTICALS PLC (HIK) Add to my list Report Summary Quotes Charts News Ratings Calendar …
WebApr 14, 2024 · Hikma Pharmaceuticals (LON:HIK – Get Rating) ‘s stock had its “buy” rating reiterated by stock analysts at Jefferies Financial Group in a report released on Wednesday, Marketbeat Ratings reports.They presently have a GBX 2,080 ($25.76) price target on the stock. Jefferies Financial Group’s target price indicates a potential upside of 15.63% from … WebInformation and tools for shareholders including our latest dividend, payments, historical data and dividend calculator. We pay dividends twice yearly. Find out more about dividends.
WebApr 11, 2024 · -- Hikma Pharmaceuticals on Wednesday said it appointed Riad Mishlawi as the group's new chief executive officer, with effect Sept. 1. Mishlawi currently serves as the president of Hikma's... April 12, 2024 ... London Stock Exchange; Hikma Pharmaceuticals PLC. News. Summary HIK GB00B0LCW083. HIKMA PHARMACEUTICALS PLC (HIK) Add … WebMar 30, 2024 · Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three...
WebHikma Pharmaceuticals Plc - ADR. HKMPY stock. $42.50. 2.41%. $7.07 B. 3.48%. $1.48-Overview - HKMPY. Overview. Ratings. Recommendation. Payouts. Div Growth. Capture Strategy. News & Research. Profile. Home Dividend Stocks Health Care Biotech Pharma Generic Pharma Hikma Pharmaceuticals Plc - ADR (HKMPY) Dividend Data
WebApr 6, 2024 · Hikma Pharmaceuticals - HKMPF News Today $20.27 -0.37 (-1.79%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $20.27 $20.27 50-Day Range $18.87 $21.36 52-Week Range $13.76 $28.00 Volume 90 shs Average Volume 237 shs Market Capitalization $4.46 billion P/E Ratio N/A Dividend Yield 3.65% Price Target N/A Profile … can stripe do recurring paymentsWeb2 days ago · 8 800. Free-Float. 66,4%. More Financials. Company. Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company’s principal activities are the development, manufacturing, marketing and selling of a range of generic, branded and in-licensed pharmaceuticals products in solid, semi-solid, liquid and injectable final dosage … flash actor on the runWebApr 12, 2024 · Hikma Pharmaceuticals' mailing address is 1 NEW BURLINGTON PLACE, LONDON X0, W1S 2HR. The official website for the company is www.hikma.com. The company can be reached via phone at 442073992760, via email at [email protected], or via fax at 44-20-7399-2761. This page (OTCMKTS:HKMPF) was last updated on … can strive be used as a nounWebMar 1, 2024 · Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded,... flash actor goes crazyWebThe stock price for . Hikma Pharmaceuticals (OTCPK: HKMPF) is $20.6401 last updated March 1, 2024 at 4:21 PM UTC. flash actors potentialWebApr 5, 2024 · Jazz Pharmaceuticals Contacts: Investors: Kathee Littrell, Vice President, Investor Relations, Ireland, +353 1 634 7887, U.S., +1 650 496 2717; Media: Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations, Ireland, +353 1 … flash actor in troubleWebHikma launches Icosapent Ethyl Capsules, 0.5g, in the US Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2024 financial results Notice of Annual General Meeting Friday 28 April 2024, 11.00 AM GMT, Sofitel London St James, 6 Waterloo Place, London SW1Y 4AN Investor insight flash actus figaro